65,437 trials
Stage IIIA Non-small Cell Lung Cancer · Stage IIIB Non-small Cell Lung Cancer · Stage IV Non-small Cell Lung Cancer
Primary: Overall Survival (OS) — 11.4; 10.5 Months — p=0.54
Cataract
Primary: Posterior Capsule Opacification (PCO) — 11.58; 14.04 Percentage of PCO
Myelodysplastic Syndromes · Thrombocytopenia
Primary: Occurrence of a Clinically Significant Thrombocytopenic Event — 8; 4; 8 Participants
Contraception
Primary: Pregnancy Rate (Expressed as Pearl Index) in Women Aged 18 to 35, MITT Population, — 2.554 Pregnancy Rate
Asthma
Primary: Time to First Asthma Exacerbation — 225.1; 249.5; 227.2 days — p=0.6625
Palmoplantaris Pustulosis
Primary: Percentage Change in Palmoplantar Pustulosis Severity Index (PPPASI) Before Crossover — 30.1; 7.1 Percentage change
Psoriasis Vulgaris
Primary: Subjects With Controlled Disease According to the Investigator Assessment of the Face at Week 8 — 183; 147; 37 Participants
Hepatitis B, Chronic
Primary: Number of Participants With Hepatitis B Envelope Antigen (HBe or HBeAg) Loss — 39; 40; 70 Participants — p=0.860
Schizophrenia · Schizoaffective Disorder · Psychotic Disorder
Primary: Mean Number of Drinking Days Per Week — 2.7 Drinking Days per Week
Deep Vein Thrombosis
Primary: Number of Patients With Clinically Relevant Bleeding Events — 32; 32 Patients
Heart Failure
Primary: C Max (Day 1, Dose 1) — 58; 243; 209 ng/mL
Cherry Angioma
Primary: Mean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded Raters — 5.27…
Breast Cancer
Primary: Scores on the Personal Resource Questionnaire 85. — 50.22; 53.44 Scores on a scale — p=.315
Atopic Dermatitis · Allergic Contact Dermatitis
Primary: Number of Patients Achieving an Improvement (Decrease) in IGA (Investigator Global Assessment) by Two or More Points — 2 participants
Acromegaly
Primary: The Percentage of Subjects or Their Partners That Are Competent to Self-administer Somatuline Autogel at the End of the Study, (Week 24/Early Termination), as Assessed…